Alnylam Pharmaceuticals Inc (ALNY)
245.50
+6.63
(+2.78%)
USD |
NASDAQ |
Dec 20, 16:00
245.46
-0.04
(-0.02%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Assets (Quarterly): 4.205B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| BridgeBio Pharma Inc | 664.98M |
| Gilead Sciences Inc | 54.52B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Sarepta Therapeutics Inc | 3.600B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.173B |
| Shareholders Equity (Quarterly) | 32.35M |
| Debt to Equity Ratio | 31.64 |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |